Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Aulos Bioscience, Inc.
Aulos Bioscience, Inc.
Intima Bioscience, Inc.
Alaunos Therapeutics
Immatics US, Inc.
NeogenTC
Fate Therapeutics
Fate Therapeutics
PACT Pharma, Inc.